Bayer licenses HIV Group O immunoassay
Selected Abstract
Bayer licenses HIV Group O immunoassay from Roche and Dade Behring.(Brief Article)
Bayer Corporation (Pittsburgh, PA; 412-777-2000) announced that it has been granted a license under patent rights of Roche Diagnostics GmbH (Basel, Switzerland; 49 621 759-23 24) and Dade Behring (Deerfield, IL; 847-267-5300), relating to the develop-ment, manufacture and marketing of immunoassays ... June 1, 2001; BIOTECH Patent News
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bayer licenses HIV Group O immunoassay from Roche and Dade Behring.(Brief Article)
|
